Open access · CC-BY
via OpenAlex
Comprehensive Review of Senotherapy
Mohamed Abudhakir S, Karpagam Kumara Sundari S
International Journal of Pharmacology and Clinical Research (IJPCR) · 2026
Genomic instability
Cellular senescence
Chronic inflammation
Senolytics
Rapamycin / mTOR inhibition
Human
Preclinical / animal
Review
Abstract
Cellular senescence(definition) is an irreversible state of cell-cycle arrest that occurs in response to aging, DNA damage, oxidative stress , oncogene activation, and other cellular insults.Although senescent cells play important roles in tissue repair and tumor suppression, their accumulation with age contributes to chronic inflammation, tissue dysfunction and age-related diseases.Senotherapy is an emerging therapeutics approach that targets senescent cells and their harmful effects.The major strategies include senolytics(definition) , which selectively eliminate senescent cells ; senomorphics, which suppress the senescence-associated secretory phenotype (SASP); and immune based approaches that enhance the clearance of senescent cells. Several senotherapeutic agents, including dasatinib, quercetin, fisetin,navitoclax, and mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), have demonstrated promising effects in preclinical studies by reducing senescent cell burden and improving tissue function and healthspan(definition). Animal studies have shown potential benefits in age-related, cardiovascular, metabolic, neurodegenerative and fibrotic disorders.Early human clinical studies have also reported promising findings, although long-term safety and efficacy remain to be established. Despite its therapeutic potential , senotherapy faces challenges such as cellular heterogeneity ,lack of specific biomarkers,off-target toxicity, and difficulties in targeted drug delivery.Further research is therefore required to develop selective senotherapeutic agents, reliable biomarkers, and effective delivery strategies.Overall,senotherapy represents a promising approach for delaying age-associated diseases and promoting healthy aging
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
S, M.A., & S, K.K.S. (2026). Comprehensive Review of Senotherapy. <em>International Journal of Pharmacology and Clinical Research (IJPCR)</em>. https://openalex.org/W7215175408
Vancouver
S MA, S KKS. Comprehensive Review of Senotherapy. International Journal of Pharmacology and Clinical Research (IJPCR). 2026.
BibTeX
@article{mohamed2026Compre,
title = {Comprehensive Review of Senotherapy},
author = {Mohamed Abudhakir S and Karpagam Kumara Sundari S},
journal = {International Journal of Pharmacology and Clinical Research (IJPCR)},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Preprints.org 2025
Preprint · CC-BY
Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases
Molecular Neurobiology 2025
Open access · CC-BY
Senolytics as Modulators of Critical Signaling Pathways: a Promising Strategy to Combat Brain Aging and Neurodegenerative Disorders
Drug design, development and therapy 2025
Open access · OA
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.
International Journal of Veterinary Sciences and Animal Husbandry 2026
Open access · OA
Senotherapeutics: emerging pharmacological strategies for targeting cellular senescence
Drug Design Development and Therapy 2025
Open access · CC-BY
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Central Asian Journal of Medical Hypotheses and Ethics 2025
Open access · CC-BY